Krystal Biotech (KRYS)
(Delayed Data from NSDQ)
$155.68 USD
-3.37 (-2.12%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $155.66 -0.02 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/13/24 |
---|---|
Current Quarter | 0.28 |
EPS Last Quarter | 0.30 |
Last EPS Surprise | 157.69% |
ABR | 1.00 |
Earnings ESP
|
-53.98% |
---|---|
Current Year | 1.89 |
Next Year | 3.96 |
EPS (TTM) | -3.38 |
P/E (F1) | 84.28 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 45.51M | 51.96M | 237.80M | 350.63M |
# of Estimates | 3 | 3 | 4 | 3 |
High Estimate | 48.33M | 57.50M | 291.60M | 412.20M |
Low Estimate | 40.00M | 41.90M | 178.00M | 251.00M |
Year ago Sales | 0.00M | 0.00M | 50.70M | 237.80M |
Year over Year Growth Est. | NA | NA | 369.05% | 47.45% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.28 | 0.23 | 1.89 | 3.96 |
# of Estimates | 4 | 3 | 7 | 5 |
Most Recent Consensus | 0.19 | 0.25 | 1.62 | 2.01 |
High Estimate | 0.62 | 0.39 | 3.84 | 10.34 |
Low Estimate | 0.08 | 0.10 | 0.38 | 0.34 |
Year ago EPS | -1.76 | -1.25 | -2.76 | 1.89 |
Year over Year Growth Est. | 115.91% | 118.40% | 168.48% | 109.68% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 2 | 2 | 6 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.28 | 0.23 | 1.89 | 3.96 |
7 Days Ago | 0.28 | 0.23 | 1.89 | 3.96 |
30 Days Ago | 0.18 | 0.12 | 1.61 | 3.69 |
60 Days Ago | -0.22 | -0.02 | -0.50 | 2.64 |
90 Days Ago | -0.22 | -0.02 | -0.64 | 2.64 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.13 | 0.20 | 0.73 | 2.83 |
Zacks Consensus Estimate | 0.28 | 0.23 | 1.89 | 3.96 |
Earnings ESP | -53.98% | -13.04% | -61.32% | -28.54% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.30 | -0.67 | -1.25 | -1.76 | NA |
Estimate | -0.52 | -1.10 | -0.42 | -1.41 | NA |
Difference | 0.82 | 0.43 | -0.83 | -0.35 | 0.02 |
Surprise | 157.69% | 39.09% | -197.62% | -24.82% | -6.42% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more